Skip to main content


What's new

At the Milken Institute 2021 Future of Health Summit, leading experts in type 1 diabetes research and innovation discussed the path toward a cure, the latest in glucose monitoring technology, and the importance of screening for type 1 diabetes. Continue Reading »

At our second virtual Musings event of the year, we heard five experts discuss type 1 diabetes preventions, delays, and cures – including the importance of screening.  Continue Reading »

At the third virtual DiabetesMine D-Data ExChange, we learned about the latest in DIY automated insulin delivery and the newest in diabetes technology from smart insulin pen caps and minimally invasive continuous glucose monitors. Continue Reading »

Highlights from The diaTribe Foundation and TCOYD panel discussion at ADA 2021 include changing standards of care, continuous glucose monitoring, and the latest in diabetes drug development. Continue Reading »

At diaTribe Musings, four expert panelists taught us how emergency glucagon can save lives during severe hypoglycemia. Read their insights on the future of glucagon and how people with diabetes can advocate for themselves. Continue Reading »

To kick-off our 6th annual diaTribe Musings series, we will be hosting a virtual panel focused on the latest innovations in glucagon therapy. Join us on May 13 to learn about how next-generation glucagon can empower people living with diabetes by preparing them for emergency situations and giving them greater peace of mind.  Continue Reading »

Advice from ophthalmologists, optometrists, endocrinologists, and people with diabetes-related eye disease on getting comprehensive eye exams. “The bottom-line is yearly eye exams prevent blindness,” said Dr. Robert Gabbay, the ADA’s Chief Scientific & Medical Officer. Continue Reading »

Highlights from The diaTribe Foundation and TCOYD panel discussion at ADA 2020 Continue Reading »